# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-01-30 | **更新时间**: 09:19 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- `[23:07]` **Avobis Bio 宣布随机多中心 STOMP2 临床试验的扩展初步分析结果将在欧洲克罗恩病和结肠炎组织 (ECCO) 大会上公布**
  <br><small>🇬🇧 *Avobis Bio Announces Expanded Primary Analysis Results from the Randomized Multicenter STOMP2 Clinical Trial to be Presented at European Crohn's and Colitis Organisation (ECCO) Congress* [🔗Source](https://news.google.com/rss/articles/CBMi2gJBVV95cUxQNFI1S3NhMWZ3ajlNNDNnMjJTQVdLSVVUOFRnOXc2eGZySUM2NTViRXkzZ2dka3BsckZuUEx3clpKcUNfNm0tcFZmRVlzSW1qOU1Vcm91TWlnM2JvVEZKQ2lkT3FEbWZCczVsYUlhVUo0eHp0OFhLQWZWUnhsd192dGM3a0dTcnFUNmlrMmJKWUlydHJiZnE2dXp3NmVYRXQzdVl0eG92Tm9fUEhENlNyOExZZ1hlN0EzM055TGgwSUlELWY0MWFrR0Q5YkF6WThLUHVhUlMzT0diWGpSdDdvRDV6YldMR0xFdUx6UlZJekF5MEctTWRUTU4tRnZ4NFJWWnQtcHRQZGlwZ2trLXdpZTF3WUJaemUzckZRZGlaM2VESUJIRVlaa0Y1Xzh0emh1ZWpWWl9LeFpkdW9Ra0pVeVFhUl9ySU11MzdQUXNsYWE0NFBaNG5FYmpn?oc=5)</small>

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[00:23]` **🏛️监管 | 刚刚！国内首款体内CAR-T获批临床** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE41RXlEUUVHNlpPRTNYZFV2MGdsMUE2dU5TbXg5U05vN2p4dGRNMVVoRk10emxlOFU2ejhkV25tclRIb1FQMGpaQkpmLXdmdFlJdUJhWHZ2eFAyQnlEdEVmSlBvR0Z4OHJXTHA3MEVYcV8xMlhZWG1OY3dydGJhZw?oc=5)
- `[22:41]` **🏛️监管 | 中国首款体内CAR-T获批临床，来自于石药** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTFBoMjJ1ZWd3ZmdydVlBU0oyQ3ZSS0JSNmU2QWNQTmRzTmdlTkloMW9tMG51dVZEODdNSjRzLS1fYXU0ZFgwWmVuZGo1WjROX0Rpd2xaUXpaU3ROc3hPb2plUnNvSVNuTHFnaUdEYllXU25JM2ZCbEhKNkl5QVdtdw?oc=5)
- `[20:29]` **🏛️监管 | 石药集团SYS6055注射液在中国临床试验获批** [🔗阅读原文](https://news.google.com/rss/articles/CBMiZkFVX3lxTE1WejJJN3p5WldaLVVrVmlpMXk3ZjZNQVJTWHZyQVJMc0Jkc1Z4YnQ1NlYzeW5pN01aUTRybC1DQnA5MGFDd3F0eE1Cc0ZHLWVvTGowaWdkVW55cDVJbjE1SUF5MUNVdw?oc=5)
- `[20:14]` **石药集团获得中国首个体内 CAR-T 疗法临床批准**
  <br><small>🇬🇧 *CSPC Wins China’s First Clinical Green Light for In Vivo CAR-T Therapy* [🔗Source](https://news.google.com/rss/articles/CBMivgFBVV95cUxQcXIzeUJ4QWY3dlRWSTVFQkVrRHVWZV90ZEpGNHZuU1ZoeFc4dUxZR1NBMlVaTWd5RURocVJqQm91cWVQcmx0UFlQRmtrdVYxbnItV2ZSeGZMRU9qOHMzN29nSDBYcTg4STdVS2VHUUltdkItVjhvc2JMRGMyMTNaS2NlSy1ieHVrSWE2eEtFVkZ4am9sbHN2VnVtZjc2UU5fUE5DRm9jQjFLTEpPOW5GZEluWGhHQ1BjNTkwSVZ3?oc=5)</small>
- `[19:01]` **实体瘤治疗新突破：靶向巨噬细胞的CAR-T疗法，如何让“冷肿瘤”变“热”？** [🔗阅读原文](https://news.google.com/rss/articles/CBMiRkFVX3lxTE42c3ktYjRZb3l0OTcyUG5XT1U3Z3d5UnZ6aEtCVUhvY1FBR0xVMkRRbTQtc0xvZ3NMZ1E5NkJnZW4zMGtud2c?oc=5)
- `[17:31]` **【文献速递】CAR-T治疗失败后，LBCL接受BsAb治疗的临床疗效：来自ABC联盟的研究结果** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE9sZENhdEZxMXBaRFFlV0hYOUotWGhvNjNIN1lkbjJCeFZXdXh6ZWkwMFY4QWNsbzZnVHpoTjNDLUU0LVU1ZW9sS3RHeDBVeE1JTDBMbld2QXZLSnIxWW9FWVRJNTVTTFhNeHotLURSUlR2OVh1akk2UDFRaTFEQQ?oc=5)
- `[14:46]` **Frontiers in Medicine丨克晓燕/胡凯教授团队：CAR-T细胞治疗对携带TP53突变的R/R CNSL患者有显著疗效** [🔗阅读原文](https://news.google.com/rss/articles/CBMiT0FVX3lxTFBnekVXaThaeUFlcEFXWTJqWUVaX3ZuVjByN080Vm9kMmJoanNQdlZ1RVI2ZW1jV0FJNmZmZ3FLT3VlNmY0bWl5OXVTdHBZVVE?oc=5)
- `[12:47]` **🏛️监管 | 4.98万/次，全国首个覆盖8种肿瘤适应症的自体NK细胞辅助治疗技术在博鳌乐城华西医院正式获批临床应用** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTFBPc0dxcElVbjc5WkhOQzByd2pHT0NwWWhFOFVWWUowODlZY0ctNFE0Vl95UVcyM0lLcjQwcEZHNklUX0Y2UVhXMF8zek9fTlBlZ0JrLVVYM2FpcXgyR3B0Q2VmTVBUYVhFNEV5WVNHcVBHQ3hCQzNMV2l3ZEhZQQ?oc=5)
